Abstract

BackgroundADHD is diagnosed and treated more often in males than in females. Research on gender differences suggests that girls may be consistently underidentified and underdiagnosed because of differences in the expression of the disorder among boys and girls. One aim of the present study was to assess in a clinical sample of medication naïve boys and girls with ADHD, whether there were significant gender x diagnosis interactions in co-existing symptom severity and executive function (EF) impairment. The second aim was to delineate specific symptom ratings and measures of EF that were most important in distinguishing ADHD from healthy controls (HC) of the same gender.MethodsThirty-seven females with ADHD, 43 males with ADHD, 18 HC females and 32 HC males between 8 and 17 years were included. Co-existing symptoms were assessed with self-report scales and parent ratings. EF was assessed with parent ratings of executive skills in everyday situations (BRIEF), and neuropsychological tests. The three measurement domains (co-existing symptoms, BRIEF, neuropsychological EF tests) were investigated using analysis of variance (ANOVA) and random forest classification.ResultsANOVAs revealed only one significant diagnosis x gender interaction, with higher rates of self-reported anxiety symptoms in females with ADHD. Random forest classification indicated that co-existing symptom ratings was substantially better in distinguishing subjects with ADHD from HC in females (93% accuracy) than in males (86% accuracy). The most important distinguishing variable was self-reported anxiety in females, and parent ratings of rule breaking in males. Parent ratings of EF skills were better in distinguishing subjects with ADHD from HC in males (96% accuracy) than in females (92% accuracy). Neuropsychological EF tests had only a modest ability to categorize subjects as ADHD or HC in males (73% accuracy) and females (79% accuracy).ConclusionsOur findings emphasize the combination of self-report and parent rating scales for the identification of different comorbid symptom expression in boys and girls already diagnosed with ADHD. Self-report scales may increase awareness of internalizing problems particularly salient in females with ADHD.

Highlights

  • IntroductionResearch on gender differences suggests that girls may be consistently underidentified and underdiagnosed because of differences in the expression of the disorder among boys and girls

  • Attention-deficit/hyperactivity disorder (ADHD) is diagnosed and treated more often in males than in females

  • In the second approach we evaluated the ability of ratings or measures in the: (1) symptom (CBCL, RCMAS-2, State-Trait Anxiety Inventory for Children (STAIC), Short Mood and Feelings Questionnaire (SMFQ)), (2) executive function (EF) test performance, and (3) EF rating (BRIEF) clusters to predict whether participants met criteria for ADHD, and if the most important predictor variables in each cluster were the same for males and females

Read more

Summary

Introduction

Research on gender differences suggests that girls may be consistently underidentified and underdiagnosed because of differences in the expression of the disorder among boys and girls. One aim of the present study was to assess in a clinical sample of medication naïve boys and girls with ADHD, whether there were significant gender x diagnosis interactions in co-existing symptom severity and executive function (EF) impairment. Worldwide prevalence estimates for childhood ADHD range between 3% and 7% [1] with a male-to-female ratio of 3:1 in population based studies [2,3] and between 5:1 to 9:1 in clinical samples [1,3,4]. Research on gender differences suggests that girls may be consistently underidentified and underdiagnosed mostly explained by differences in the expression of the disorder among boys and girls [3,5,6,7]. Sciutto, Nolfi, & Bluhm [12] found that teachers more often refer boys than girls for treatment for ADHD, even when showing equal levels of impairment

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call